ID   SBC-3/DXCL1
AC   CVCL_M843
DR   Wikidata; Q54952173
RX   PubMed=9914787;
CC   Population: Japanese.
CC   Doubling time: 33.3 hours (PubMed=9914787).
CC   Selected for resistance to: ChEBI; CHEBI:31587; Exatecan mesilate hydrate (DX-8951f).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1678 ! SBC-3
SX   Male
AG   24Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 13
//
RX   PubMed=9914787; DOI=10.1111/j.1349-7006.1998.tb00513.x;
RA   Nomoto T., Nishio K., Ishida T., Mori M., Saijo N.;
RT   "Characterization of a human small-cell lung cancer cell line
RT   resistant to a new water-soluble camptothecin derivative, DX-8951f.";
RL   Jpn. J. Cancer Res. 89:1179-1186(1998).
//